Atheroembolism is a systemic condition, caused by showers of cholesterol crystals breaking off from plaques in large arteries. The crystals travel into smaller blood vessels and block blood flow.1 It is also called cholesterol embolization, and, from what it does to the toes, “blue toe” or “purple toe”.
A blue or purple toe that appears suddenly calls for a search for the source. If the plaque that shed the debris is left in place, it can shed more.
The crystals lodge in the tiny arteries of the foot (the arterioles).2 They cause an intense inflammatory reaction around the arterioles they block, and the skin and tissue they supply lose their blood. The result is a painful, discolored toe or patch of skin on the foot.2
Its characteristic skin findings are livedo reticularis, a net-like purple mottling of the skin; blue toe syndrome; and painful ulcers.1,3
Where the debris comes from
It happens in two settings:1,3
- On its own. A plaque with a broken, ulcerated surface sheds debris without any trigger (a case). The source is not always a plaque. In a man in his mid 60s, a heavy smoker, severe pain came on suddenly in his foot and several of his toes turned purple. The source was a tibial osteophyte, a bony spur at the top of the shin bone, pressing on the popliteal artery behind the knee. The artery had narrowed and become irregular where the spur pressed on it, and it had showered debris down to the toes.
- After a procedure on the arteries. Wires, balloons and atherectomy devices disturb plaque, and crystals can break off and travel to the foot.
Treatment
In most cases the injury is limited: an area of skin is lost and then heals. Sometimes a toe has to be amputated. Rarely, the embolization is so extensive that it threatens the limb.
There is no proven treatment that improves the outcome once the crystals have lodged: medicines that damp down the inflammation have been tried, with conflicting results.1 Care is directed at the skin and at the source.
Treating the source. A plaque that is shedding debris can be removed with atherectomy, sealed off with a covered stent, or both. The choice depends on the plaque and where it is in the artery. In one case, directional atherectomy was used. The patient’s symptoms resolved and had not come back two years later. In a man whose toes turned purple from a bony spur pressing on the popliteal artery, atherectomy was used, and a stent graft, a covered stent, was placed for a perforation of the artery. Treatment saved his toes, and the spur itself was removed later, electively, once his medical care had been optimized.
Risk-factor care. Stopping smoking, a statin for cholesterol, blood pressure control and an antiplatelet medicine such as aspirin, as for all peripheral arterial disease.
The plaque that showers a toe is atherosclerosis, and peripheral arterial disease overlaps with coronary artery disease and cerebrovascular disease: the same disease can affect the arteries that supply the legs, the heart and the brain. A sudden blue or purple toe brings that wider risk to attention, and these medicines are there to lower the risk of heart attack and stroke. Treating the artery responsible for the toe is one part of care. Optimizing overall vascular care to reduce the risk of heart attack and stroke is just as important.
References
- Ozkok A. Cholesterol-embolization syndrome: current perspectives. Vasc Health Risk Manag. 2019;15:209–220. https://doi.org/10.2147/VHRM.S175150
- Kronzon I, Saric M. Cholesterol embolization syndrome. Circulation. 2010;122(6):631–641. https://doi.org/10.1161/CIRCULATIONAHA.109.886465
- Paraskevas KI, Koutsias S, Mikhailidis DP, Giannoukas AD. Cholesterol crystal embolization: a possible complication of peripheral endovascular interventions. J Endovasc Ther. 2008;15(5):614–625. https://doi.org/10.1583/08-2395.1